Jiankang Zhang

发表

Exploiting polypharmacology for improving therapeutic outcome of kinase inhibitors (KIs): An update of recent medicinal chemistry efforts.

Xiaodong Ma, Xiaoqing Lv, Xiaodong Ma, 2018, European journal of medicinal chemistry.

Clinical and marketed proteasome inhibitors for cancer treatment.

Yongzhou Hu, Peng Wu, Jiankang Zhang, 2013, Current medicinal chemistry.

Discovery of 3-(thiophen/thiazole-2-ylthio)pyridine derivatives as multitarget anticancer agents

Shourong Liu, Jiankang Zhang, Jian-Jun Xi, 2019, Medicinal Chemistry Research.

Discovery of a series of N-(5-(quinolin-6-yl)pyridin-3-yl)benzenesulfonamides as PI3K/mTOR dual inhibitors.

Xiaodong Ma, Xiaoqing Lv, Jiankang Zhang, 2017, European journal of medicinal chemistry.

Synthesis and evaluation of a series of pyridine and pyrimidine derivatives as type II c-Met inhibitors.

Jinming Pan, Shourong Liu, Xiaoqing Lv, 2017, Bioorganic & medicinal chemistry.

Development of Macrocyclic Peptides Containing Epoxyketone with Oral Availability as Proteasome Inhibitors.

J. Yu, Xiaodong Ma, Xiaowu Dong, 2018, Journal of medicinal chemistry.

Exploration of novel piperazine or piperidine constructed non-covalent peptidyl derivatives as proteasome inhibitors.

Yu-bo Zhou, Jia Li, Shourong Liu, 2017, European journal of medicinal chemistry.

Identification of 3-amidoquinoline derivatives as PI3K/mTOR dual inhibitors with potential for cancer therapy

Xiaodong Ma, Shuyu Zhan, Xiaoqing Lv, 2017 .

Optimization of piperidine constructed peptidyl derivatives as proteasome inhibitors.

Yu-bo Zhou, Jia Li, Lei Xu, 2020, Bioorganic & medicinal chemistry.

Identification of Novel Piperazinylquinoxaline Derivatives as Potent Phosphoinositide 3-Kinase (PI3K) Inhibitors

Yongzhou Hu, Xiaowu Dong, Peng Wu, 2012, PloS one.

Novel 4-Acrylamido-Quinoline Derivatives as Potent PI3K/mTOR Dual Inhibitors: The Design, Synthesis, and in vitro and in vivo Biological Evaluation

Xiaodong Ma, Shuyu Zhan, Baoyue Ding, 2019, Front. Chem..

Design, synthesis and biological evaluation of novel tripeptidyl epoxyketone derivatives constructed from β-amino acid as proteasome inhibitors.

Jia Li, Tao Liu, Lei Xu, 2014, Bioorganic & medicinal chemistry.

Covalent docking modelling-based discovery of tripeptidyl epoxyketone proteasome inhibitors composed of aliphatic-heterocycles.

Yongzhou Hu, Xiaowu Dong, J. Che, 2019, European journal of medicinal chemistry.

Design, Synthesis and Biological Evaluation of Peptidyl Epoxyketone Proteasome Inhibitors Composed of β‐amino Acids

Jia Li, Yongzhou Hu, Xiaodong Ma, 2014, Chemical biology & drug design.

Exploration of novel four-membered-heterocycle constructed peptidyl proteasome inhibitors with improved metabolic stability for cancer treatment.

G. Wei, Jia Li, Li-xin Gao, 2023, Bioorganic chemistry.

Design, synthesis and biological evaluation of novel non-covalent piperidine-containing peptidyl proteasome inhibitors.

Jia Li, Yidan Shao, Shourong Liu, 2016, Bioorganic & medicinal chemistry.